The Impact of Qualia Gluthathione+ on Blood Glutathione Levels
Part of paid clinical trials in Carlsbad, California.
- Sponsor
- Qualia Life Sciences
- Study ID
- NCT07221955
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Effects of Qualia Glutathione+ on Blood Glutathione Levels
- Glutathione
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Qualia Glutathione+ version 1 — DIETARY_SUPPLEMENTQualia Glutathione+ version 1 manufactured by Qualia Life Sciences
- Qualia Glutathione+ version 2 — DIETARY_SUPPLEMENTQualia Glutathione+ version 2 manufactured by Qualia Life Sciences
- Placebo — DIETARY_SUPPLEMENTRice flour
Study Details
This is a randomized, double-blind, placebo-controlled, parallel-group, triple-armed, study evaluating the effects of two distinct Qualia Glutathione+ formulations on Whole Blood Glutathione levels in the blood of healthy adults aged 45-75 years. Approximately 18 participants will be randomized to one of three study arms: Qualia Glutathione+ version 1, Qualia Glutathione+ version 2, or placebo. Each participant will take two or three capsules of their assigned product once daily in the morning, with or without food, over a 20-day period. The primary outcome is the change in blood glutathione levels, assessed via in lab blood collection at baseline and study completion. Secondary endpoints include questionnaires measuring health-related quality of life, fatigue, and cognitive functioning (PROMIS Global Health-10, PROMIS Short Form v1.0 - Fatigue 10a, PROMIS Cognitive Function - Short Form 8a), evaluation of safety and tolerability, and an Overall Experience Questionnaire (Appendices 1, 4-7). All assessments, including electronic questionnaires, are completed remotely without in-person visits.
Key Dates
- Start date
- Dec 2, 2025
- Status verified
- Nov 2025
- Primary completion
- Dec 22, 2025
- Completion
- Jan 25, 2026
Study Design
- Enrollment
- 54 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Qualia Glutathione+ version 1Qualia Glutathione+ version 1 manufactured by Qualia Life Sciences
- Active Comparator: Qualia Glutathione+ version 2Qualia Glutathione+ version 2 manufactured by Qualia Life Sciences
- Placebo Comparator: PlaceboRice flour placebo
Primary Outcome Measure
Total Glutathione levels from baseline to Day 20 [ Time Frame: 0-20 days ]
Central Contacts
- William Scuba855-281-2328
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Qualia Life Sciences | Carlsbad | California | 92011 |